FSR vs OKUR
FSR (FSR) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
FSR (FSR) common stock.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
FSR does not have a complete income-statement cache yet.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the FSR and OKUR stock pages for the full models.
Not investment advice.